$14.64
0.90% today
NYSE, Apr 02, 09:16 pm CET
ISIN
US58502B1061
Symbol
MD

MEDNAX, Inc. Stock price

$14.51
+0.00 0.00% 1M
+2.51 20.92% 6M
+1.39 10.59% YTD
+4.77 48.97% 1Y
-9.50 39.57% 3Y
+3.70 34.23% 5Y
-56.97 79.70% 10Y
NYSE, Closing price Tue, Apr 01 2025
+0.02 0.14%
ISIN
US58502B1061
Symbol
MD
Sector

Key metrics

Market capitalization $1.25b
Enterprise Value $1.56b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 8.45
EV/Sales (TTM) EV/Sales 0.77
P/S ratio (TTM) P/S ratio 0.62
P/B ratio (TTM) P/B ratio 1.63
Revenue growth (TTM) Revenue growth 0.92%
Revenue (TTM) Revenue $2.01b
EBIT (operating result TTM) EBIT $183.68m
Free Cash Flow (TTM) Free Cash Flow $184.55m
Cash position $348.51m
EPS (TTM) EPS $-1.20
P/E forward 10.63
P/S forward 0.67
EV/Sales forward 0.84
Short interest 4.75%
Show more

Is MEDNAX, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

MEDNAX, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a MEDNAX, Inc. forecast:

3x Buy
38%
5x Hold
63%

Analyst Opinions

8 Analysts have issued a MEDNAX, Inc. forecast:

Buy
38%
Hold
63%

Financial data from MEDNAX, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,013 2,013
1% 1%
100%
- Direct Costs 1,591 1,591
1% 1%
79%
422 422
10% 10%
21%
- Selling and Administrative Expenses 206 206
8% 8%
10%
- Research and Development Expense - -
-
-
216 216
11% 11%
11%
- Depreciation and Amortization 32 32
11% 11%
2%
EBIT (Operating Income) EBIT 184 184
16% 16%
9%
Net Profit -99 -99
64% 64%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about MEDNAX, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MEDNAX, Inc. Stock News

Neutral
Seeking Alpha
about one month ago
Pediatrix Medical Group, Inc. (NYSE:MD ) Q4 2024 Earnings Conference Call February 20, 2025 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance & Strategy Mark Ordan - Chief Executive Officer Kasandra Rossi - Executive Vice President, Chief Financial Officer & Treasurer Conference Call Participants A.J. Rice - UBS Jack Levin - Jefferies Whit Mayo - Leerink Partners Be...
Neutral
Business Wire
about one month ago
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Fourth Quarter Results.
Neutral
Business Wire
about 2 months ago
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD #ContinuingEducation--NEO: The Conference for Neonatology is a premier educational event dedicated to advancing the field of neonatology.
More MEDNAX, Inc. News

Company Profile

MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company's solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. MEDNAX was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Head office United States
CEO Mark Ordan
Employees 6,455
Founded 1979
Website www.pediatrix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today